alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED> 
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          FEB-01-1997
<PERIOD-START>                             FEB-04-1996
<PERIOD-END>                               FEB-01-1997
<EXCHANGE-RATE>                                      1
<CASH>                                          12,348
<SECURITIES>                                         0
<RECEIVABLES>                                   97,274
<ALLOWANCES>                                     1,200
<INVENTORY>                                    161,230
<CURRENT-ASSETS>                               311,803
<PP&E>                                         170,805
<DEPRECIATION>                                 145,467
<TOTAL-ASSETS>                                 621,789
<CURRENT-LIABILITIES>                          127,361
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           349
<OTHER-SE>                                     431,110
<TOTAL-LIABILITY-AND-EQUITY>                   621,789
<SALES>                                      1,018,801
<TOTAL-REVENUES>                             1,018,801
<CGS>                                          648,710
<TOTAL-COSTS>                                  910,029
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               5,324
<INCOME-PRETAX>                                103,448
<INCOME-TAX>                                    39,827
<INCOME-CONTINUING>                             63,621
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    63,621
<EPS-PRIMARY>                                     1.92
<EPS-DILUTED>                                     1.91
        

</TABLE>
Motion Granted; Appeal Dismissed and Memorandum Opinion filed 

February 5, 2015.

In The

Fourteenth Court of Appeals

NO. 14-14-00898-CV

HARRIS COUNTY HOSPITAL DISTRICT, Appellant

V.

SOLOMON NWOKO, Appellee

On Appeal from the 80th District Court

Harris County, Texas

Trial Court Cause No. 2013-27950

M E M O R A N D U M O P I N I O N

This is an accelerated appeal from an order signed October 17, 2014. On 

February 2, 2015, appellant filed a motion to dismiss the appeal because the case 

has settled. See Tex. R. App. P. 42.1. The motion is granted. 

Accordingly, the appeal is ordered dismissed.

PER CURIAM

Panel consists of Justices Jamison, Busby, and Brown.
#### FRANCIS A. MINITER *v.*STATEWIDE GRIEVANCE COMMITTEE ET AL.

*Francis A. Miniter,*pro se, in support of the petition.

*Mark A. Dubois,*in opposition.

Decided June 9, 2010

The plaintiffs petition for certification for appeal from the Appellate Court, 120 Conn. App. 904 (AC 31209), is denied.
<PAGE>
                                                                    EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of INCOME GROWTH PARTNERS, LTD. X (the
"Company") on Form 10-QSB for the period ending June 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy
C. Maurer, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

      (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

/s/ Timothy C. Maurer

Timothy C. Maurer
Chief Financial Officer
August 8, 2003
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
                             FINANCIAL DATA SCHEDULE

     This  schedule  contains  summary  information  extracted  from the Balance
Sheet,  Statement  of  Operations,  Statement  of Cash  Flows and Notes  thereto
incorporated  in Part I, Item 7, of this Form 10 - KSB and is  qualified  in its
entirety by reference to such financial statements. </LEGEND>

<S>                                                <C>
<PERIOD-TYPE>                                      12-mos
<FISCAL-YEAR-END>                                  Mar-31-2000
<PERIOD-END>                                       Mar-31-2000
<CASH>                                             5,788,288
<SECURITIES>                                       0
<RECEIVABLES>                                      2,300,000
<ALLOWANCES>                                       0
<INVENTORY>                                        0
<CURRENT-ASSETS>                                   8,149,239
<PP&E>                                             817,822
<DEPRECIATION>                                     (436,205)
<TOTAL-ASSETS>                                     8,555,891
<CURRENT-LIABILITIES>                              370,029
<BONDS>                                            0
<PREFERRED-MANDATORY>                              0
<PREFERRED>                                        0
<COMMON>                                           0
<OTHER-SE>                                         8,104,798
<TOTAL-LIABILITY-AND-EQUITY>                       8,555,891
<SALES>                                            40,000
<TOTAL-REVENUES>                                   0
<CGS>                                              0
<TOTAL-COSTS>                                      7,389,148
<OTHER-EXPENSES>                                   0
<LOSS-PROVISION>                                   0
<INTEREST-EXPENSE>                                 0
<INCOME-PRETAX>                                    0
<INCOME-TAX>                                       0
<INCOME-CONTINUING>                                0
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                                       (7,230,277)
<EPS-BASIC>                                      (0.56)
<EPS-DILUTED>                                      (0.56)



</TABLE>
EXHIBIT 10.27  AMENDMENT # 2 to the LICENSE AGREEMENT  THIS AMENDMENT #2, is made and effective retroactively to the 1st day of January 2007 (Amendment #2
Effective Date), by and between Cubist Pharmaceuticals, Inc.
a Delaware corporation having its principal place of business at 65 Hayden
Avenue, Lexington, Massachusetts  02421,
USA (Cubist) and Chiron Healthcare Ireland
Ltd. A company organized under the laws of Ireland with offices at
United Drug House, Belgard Road, Tallaght, Dublin, Ireland (Chiron).  WHEREAS, Chiron and Cubist entered into a License Agreement  effective as of October 3, 2003 with
respect to Cubicin® (daptomycin), and as
amended by an April 1, 2004 Amendment #1 (the Agreement);and  WHEREAS, pursuant to the License Agreement, Cubist granted to Chiron,
by itself or through its affiliates, the exclusive right (even to Cubist) to, inter alia, Commercialize the Licensed Products in the
Territory, as listed in Exhibit D of the Agreement; and  WHEREAS, the parties hereto now mutually desire to amend, modify and
restate certain terms and conditions of the Agreement to, inter alia,
add Romania to the territory.  NOW, THEREFORE, the parties hereto, intending to be legally bound,
agree as follows:  1.DEFINITIONS  The definitions set forth in the Agreement are hereby incorporated and
utilized for the purposes of this Amendment #2.  2.TERRITORY  The Parties agree that Romania will be added to the Territory.  Exhibit D of the Agreement is hereby
deleted and replaced by the new Exhibit D, attached hereto.  3.ENTIRE
AGREEMENT  The parties hereby agree that apart from the Exhibit of the
Agreement specifically amended hereunder, all terms and conditions of the
Agreement remain and shall remain in full force and effect.  The parties agree that this Amendment #2 is intended to form part of
the arrangements contained in the Agreement. 
The Agreement, as modified by this Amendment #2, constitutes the entire
agreement between the parties in relation to the matters contained in this
Amendment #2 and the Agreement and supersede all prior and/or contemporary


agreements and understanding that may exist between the parties,
whether written, oral or otherwise.  IN WITNESS WHEREOF, the parties hereto have caused this Amendment #2 to
be executed by their duly authorized representatives in duplicate originals as
of the Amendment #2 Effective Date.   Cubist Pharmaceuticals, Inc./s/ Thomas J. SlaterName: Thomas J. SlaterTitle: VP Commercial DevelopmentDate: May 1, 2007Chiron Healthcare Ireland Ltd./s/ Liouba LaederichName: Liouba LaederichTitle: Legal CounselDate: 25 April 2007
  2
window.addEventListener("load", (event) => {
    jQuery('table.fsrd-sortable').tablesorter({"theme": "fsrd"});
});
/**
 * Usage:  Place an empty div with the css class "fsrd-jump-links" in a container.  
 * Optionally set the minimum number of links with data-min-links attribute on the div.
 * 
 * 
 * Script locates all H2 and H3 with an id in the container and populates the div with title and links
 * if there are more than zero items.
 * 
 */

function populateJumpLinks(element) {

  // Set the minimum number of target headings required before displaying.
  let minHeadings = 2;
  if (element.hasAttribute("data-min-links")) {
    let minHeadingsStr = element.getAttribute("data-min-links");
    let minHeadingsInt = parseInt(minHeadingsStr);
    if (!isNaN(minHeadingsInt)) {
      minHeadings = minHeadingsInt;
    }
  }


  // Get the tab in which the element is contained
  let tab = element.parentElement;


  let links = [];

  // Cycle through the headings
  let headings = tab.querySelectorAll("h2, h3");
  headings.forEach((heading) => {
    {
      let headingID = heading.id;
      if (headingID.length > 0) {
        if (!heading.hasAttribute("jumplinks-ignore")) {
          let link = document.createElement("a");
          link.innerText = heading.innerText;
          link.href = 'javascript:void(0);';
          link.setAttribute('onclick', `javascript:document.getElementById('${headingID}').scrollIntoView();` );
          link.classList.add("fsrd-jump-links__link");
          links.push(link);
        }
      }
    }
  });

  if (links.length >= minHeadings) {
    // If there are any links, populate the element.
    let title = document.createElement("span");
    title.classList.add("fsrd-jump-links__title");
    title.innerText = "Jump to:";
    element.appendChild(title);

    links.forEach((link) => {
      {
        element.appendChild(link);
      }
    });
  } else {
    // Since there are no links, hide the element
    element.style.display = "none";
  }
}

Drupal.behaviors.fsJumpToLinks = {
  attach: function (context, settings) {
    once("fsJumpToLinks", ".fsrd-jump-links", context).forEach(function (
      element
    ) {
      populateJumpLinks(element);
    });
  },
};
Exhibit 4.6

 

Classification: Confidential

 

NOVATION CERTIFICATE

 

To: THE ROYAL BANK OF SCOTLAND PLC as Agent 

 

From: LLOYDS BANK  PLC and TD BANK EUROPE LTD 

 

Date:   11 December 2019

 

Vodafone Group Pie U.S.$3,395,000,000 (as increased to U.5.$ 4,090,000,000) Revolving Credit Agreement dated 27 February 2015 (as amended from and /restated from time to time)

 

We refer to Clause 27 .4 (Procedure for novations).

 

1. We Lloyds  Bank plc (the “Existing Lender”) and TD Bank Europe  Ltd  (the  “New Lender”) agree to the  Existing Lender and the  New Lender novatlng all the  Existing Lender’s rights and obligations referred to in the Schedule in accordance with Clause 27.4 (Procedure for novations).

 

2. The specified date for the purposes of Clause 27.4(c) (Procedure for novations) is  ]?”December 2019.

 

3. The Facility Office and address for notices of the  New Lender for the purposes of Clause 33.2 (Addresses for notices) are set out in the Schedule.

 

4. The New Lender confirms that it has given notice to Vodafone of the entry into of this Novation Certificate and has obtained Vodafone’s consent in accordance with Clause 27.2(c)(i)  (Transfers by Lenders).

 

5. This Novation Certificate and any non-contractual obligations arising out of or in connection with it are governed  by English  law.

 

 

THE SCHEDULE

 

Rights and obligations to be novated

 

 

Revolving Credit Facility – USD 77,500,000.00

 

 

TD BANK EUROPE  LTD

 

Facility Office Address for notices – existing lender

 











 

Classification: Confidential

 

 


	
LLOYDS BANK PLC
    	
 
    	
TD BANK  EUROPE LTD
    	
 
    	
THE ROYAL BANK OF 
   SCOTLAND PLC
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
By:
    	

    	
 
    	
By:
    	

    	
 
    	

    
	
 
    	
 
    	
Andrew Williams
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Date:
    	
 
    	
Date: 17/12/19
    	
 
    	
bate.   [7/12z/ /
#### Daniel CARDENAS-RUBIO, Petitioner, v. Eric H. HOLDER, Jr., Attorney General, Respondent.

No. 08-73884.

United States Court of Appeals, Ninth Circuit.

Submitted Dec. 14, 2010.*

Filed Jan. 6, 2011.

Sanjay Sobti, Esquire, Corona, CA, for Petitioner.

Lisa Marie Arnold, Senior Litigation Counsel, OIL, U.S. Department of Justice, Chief Counsel Ice, Office of the Chief Counsel, Department of Homeland Security, San Francisco, CA, for Respondent.

Before: GOODWIN, WALLACE, and THOMAS, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Daniel Cardenas-Rubio, a native and citizen of Mexico, petitions for review of the Board of Immigration Appeals’ (“BIA”) order denying his motion to reopen removal proceedings. Our jurisdiction is governed by 8 U.S.C. § 1252. We deny in part and dismiss in part the petition for review.

In his opening brief, Cardenas-Rubio failed to address, and therefore has waived any challenge to, the BIA’s dispositive determination that his motion was untimely without exception. *See Martinez-Serrano v. INS,*94 F.3d 1256, 1259-60 (9th Cir.1996) (issues not specifically raised and argued in a party’s opening brief are waived).

We lack jurisdiction to review Cardenas-Rubio’s ineffective assistance of counsel contention because he failed to raise that issue before the BIA. *See Barron v. Ashcroft,*358 F.3d 674, 678 (9th Cir.2004) (this court lacks jurisdiction to review contentions not raised before the agency).

Cardenas-Rubio’s contention that the BIA violated his due process rights by disregarding his hardship evidence is not supported by the record and does not amount to a colorable constitutional claim. *See Martinez-Rosas v. Gonzales,*424 F.3d 926, 930 (9th Cir.2005) (“[Traditional abuse of discretion challenges recast as alleged due process violations do not constitute colorable constitutional claims that would invoke our jurisdiction.”).

Cardenas-Rubio’s remaining contentions are unavailing.

PETITION FOR REVIEW DENIED in part; DISMISSED in part.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
<PAGE>

                                                                   EXHIBIT 99.1




                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Southeast Acquisitions II,
L.P. (the "Partnership") on Form 10-Q (the "Report") for the period ending
September 30, 2002 as filed with the Securities and Exchange Commission on or
about the date hereof, Richard W. Sorenson, the principal executive officer of
the Partnership, hereby certifies, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)    The Report fully complies with the requirements of section 13
                (a) or 15 (d) of the Securities Exchange Act of 1934; and

         (2)    The information contained in the Report fairly presents, in all
                material respects, the financial condition and result of
                operations of the Partnership.



/s/ Richard W. Sorenson
-------------------------------------
Richard W. Sorenson,
Principal Executive Officer & Member
Southern Management Group, LLC
November 14, 2002


<PAGE>



                                                                  EXHIBIT 99.1



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Southeast Acquisitions II,
L. P. (the "Partnership") on Form 10-Q (the "Report") for the period ending
September 30, 2002 as filed with the Securities and Exchange Commission on or
about the date hereof, Laura E. Ristvedt, the principal financial officer of the
Partnership, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

         (3)    The Report fully complies with the requirements of section 13
                (a) or 15 (d) of the Securities Exchange Act of 1934; and

         (4)    The information contained in the Report fairly presents, in all
                material respects, the financial condition and result of
                operations of the Partnership.



/s/ Laura E. Ristvedt
---------------------------------
Laura E. Ristvedt
Principal Financial Officer
November 14, 2002
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<EXCHANGE-RATE>                                      1
<CASH>                                           3,749
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                          31,644
<DEPRECIATION>                                  12,707
<TOTAL-ASSETS>                                  23,779
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      13,655
<TOTAL-LIABILITY-AND-EQUITY>                    23,779
<SALES>                                              0
<TOTAL-REVENUES>                                 4,762
<CGS>                                                0
<TOTAL-COSTS>                                    3,838
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 129
<INCOME-PRETAX>                                    795
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                795
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       795
<EPS-PRIMARY>                                    22.48
<EPS-DILUTED>                                    22.48
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          FEB-01-1997
<PERIOD-START>                             FEB-04-1996
<PERIOD-END>                               NOV-02-1996
<CASH>                                           1,694
<SECURITIES>                                         0
<RECEIVABLES>                                    5,387
<ALLOWANCES>                                       137
<INVENTORY>                                     50,245
<CURRENT-ASSETS>                                68,714
<PP&E>                                          58,606
<DEPRECIATION>                                  26,789
<TOTAL-ASSETS>                                 104,865
<CURRENT-LIABILITIES>                           53,037
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             8
<OTHER-SE>                                      40,468
<TOTAL-LIABILITY-AND-EQUITY>                   104,865
<SALES>                                         35,022
<TOTAL-REVENUES>                                35,022
<CGS>                                           25,473
<TOTAL-COSTS>                                   15,357
<OTHER-EXPENSES>                                  (718)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 325
<INCOME-PRETAX>                                 (5,415)
<INCOME-TAX>                                    (2,134)
<INCOME-CONTINUING>                             (3,281)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (3,281)
<EPS-PRIMARY>                                   ($0.42)
<EPS-DILUTED>                                   ($0.42)
        

</TABLE>